Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-25

FDA Approved: SODIUM POLYSTYRENE SULFONATE — Supplemental Application (PuraCap Laboratories, LLC)

View source ↗

Summary

FDA approves a supplemental application for sodium polystyrene sulfonate from PuraCap Laboratories, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sodium polystyrene sulfonate (Sodium polystyrene sulfonate)

Snippet

SUPPL AP for SODIUM POLYSTYRENE SULFONATE (SODIUM POLYSTYRENE SULFONATE)